A comparative study of blood-based KRAS mutation analysis in circulating tumor cells versus circulating plasma DNA to predict primary tumor mutations in lung cancer.

E.K.S. Lim, M.B. Freidin, D.V. Freydina, D. Chudasama, M. Leung, S. Popat, D.G. de Castro, A. Rice, V. Anikin, A.M. Fernandez, A.G. Nicholson

Research output: Contribution to conferenceOtherpeer-review

Cite this